Feature Channels: Pharmaceuticals

Filters close

Not for public release

This news release is embargoed until 7-Aug-2023 2:05 PM EDT Released to reporters: 7-Aug-2023 2:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 7-Aug-2023 2:05 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 3-Aug-2023 5:05 PM EDT
Deep learning for new protein design
University of Texas at Austin (UT Austin)

The key to understanding proteins — such as those that govern cancer, COVID-19, and other diseases — is quite simple. Identify their chemical structure and find which other proteins can bind to them. But there’s a catch.

   
Released: 3-Aug-2023 4:05 PM EDT
After 7 years, generative AI succeeds in predicting clinical trial outcomes
Insilico Medicine

Since its inception in 2014, Insilico Medicine has developed multiple AI models for predicting the probability of success of clinical trials focusing on Phase II to Phase III transition probabilities.

   
Newswise: Injection of Hope: How Botox Keeps Migraines at Bay
Released: 3-Aug-2023 3:05 PM EDT
Injection of Hope: How Botox Keeps Migraines at Bay
LifeBridge Health

Dr. Santiago Mazuera, head of Sinai Hospital's Headache Clinic, shares how Botox treatments can drastically improve quality of life for those who experience chronic migraines.

Newswise: New Study Explores the Role of Metformin in Ameliorating HMGB1-Mediated Oxidative Stress in Periodontitis
Released: 3-Aug-2023 1:00 PM EDT
New Study Explores the Role of Metformin in Ameliorating HMGB1-Mediated Oxidative Stress in Periodontitis
Chinese Academy of Sciences

A recent study reveals that Metformin, a common drug used to manage Type 2 Diabetes, could offer new hope for treating periodontitis, a chronic inflammatory disease affecting oral tissues. The study explored the effects of Metformin on HMGB1 (High Mobility Group Box 1), an inflammation mediator implicated in oxidative stress during periodontitis.

Newswise: July Research Highlights
Released: 3-Aug-2023 12:05 PM EDT
July Research Highlights
University of Utah Health

Huntsman Cancer Institute investigators find a way to reduce infection after pancreatic surgery, discover the best treatment combination that’s cost effective for prostate cancer patients, and learn lung cancer patients receiving chemotherapy have more emergency department visits. They also found a genetic mutation that makes anemia more likely after chemotherapy, and a non-invasive way to remove brain tumors.

Newswise: Researchers find drugs that reduce infant death may lead to long-term health issues
31-Jul-2023 2:05 PM EDT
Researchers find drugs that reduce infant death may lead to long-term health issues
McMaster University

Corticosteroids are used to increase very preterm infant survival rates and reduce health issues, however the effects on the infant’s long-term health have not been well understood, particularly in infants who exceed expectations and are born at term. The research suggests that many babies exposed to steroids avoid preterm birth, but new risks for other future health complications are introduced

Newswise: World Health Organization Includes the Cardiovascular Polypill in Its List of Essential Medicines After a Groundbreaking Study Led by the President of Mount Sinai Heart
Released: 2-Aug-2023 10:30 AM EDT
World Health Organization Includes the Cardiovascular Polypill in Its List of Essential Medicines After a Groundbreaking Study Led by the President of Mount Sinai Heart
Mount Sinai Health System

The cardiovascular polypill, developed by the Spanish National Centre for Cardiovascular Research (CNIC) and the pharmaceutical company Ferrer, has been included by the World Health Organization (WHO) in its List of Essential Medicines.

Released: 1-Aug-2023 4:05 PM EDT
Waters Launches XBridge Premier GTx BEH SEC Columns for Gene Therapy Applications
Waters Corporation

Waters Corporation (NYSE:WAT) introduced the first in a new line of size exclusion chromatography (SEC) columns aimed at improving the analysis while lowering the cost of gene therapies, specifically adeno-associated viral (AAV) vectors.

   
Newswise: New Study Sheds Light on the gating mechanism of Ion Channels
Released: 1-Aug-2023 8:10 AM EDT
New Study Sheds Light on the gating mechanism of Ion Channels
University of Vienna

Ion channels play a crucial role in many cellular processes, including neuronal communication, muscle contraction or cell proliferation. Most multi subunit ion channels exist in two functional states, either closed or open. During gating, one should expect that all subunits undergo conformational changes. The absence of intermediate conduction levels is surprising and asks for an explanation. A team of researchers from the University of Vienna and the Washington University in St. Louis created a smart model system to answer this important question. The study is currently published in Nature Communications.

   

Not for public release

This news release is embargoed until 31-Jul-2023 5:00 PM EDT Released to reporters: 25-Jul-2023 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 31-Jul-2023 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 31-Jul-2023 4:40 PM EDT
Oxycodone prescriptions after delivery not linked to longer-term opioid use compared to codeine prescriptions
Canadian Medical Association Journal

Postpartum prescriptions for oxycodone were not associated with increased risk of longer-term opioid use compared to codeine prescriptions, according to new research published in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.221351.

Released: 31-Jul-2023 2:05 PM EDT
New process makes it easier to craft amino acids that don’t exist in nature
University of Pittsburgh

A team including University of Pittsburgh researchers uses computer modeling and new ways of employing enzymes to create never-before-seen amino acids.

Released: 28-Jul-2023 8:55 AM EDT
Targeting TAK1 protein to treat systemic sclerosis
Michigan Medicine - University of Michigan

Systemic sclerosis is the scaring of multiple organs within the body resulting in difficulty in functioning for these organs. The disease can become deadly if the organ scaring isn’t treated properly. Researchers at the University of Michigan Health System have identified a protein in the disease that may be a new target for treatment.

Released: 26-Jul-2023 5:30 PM EDT
NIH spent $950M for basic or applied research leading to patents providing market exclusivity for drugs approved 2010-19
Bentley University

A new demonstrates that the National Institutes of Health (NIH) spent $950 million on basic or applied research associated with patents that provided manufacturers with market exclusivity.

   
19-Jul-2023 10:00 AM EDT
Breaking Research on Advances in Drug Testing for Marijuana and Fentanyl
Association for Diagnostic and Laboratory Medicine (ADLM (formerly AACC))

Two studies featured today at the 2023 AACC Annual Scientific Meeting & Clinical Lab Expo highlight advances that could boost the accuracy of marijuana tests and provide vital information for addressing the opioid epidemic.

Released: 26-Jul-2023 8:00 AM EDT
MD Anderson and Nexo Therapeutics announce strategic research collaboration to advance new therapies against intractable targets
University of Texas MD Anderson Cancer Center

MD Anderson and Nexo announced a strategic research collaboration to rapidly advance new cancer therapies against previously undruggable targets.

Released: 25-Jul-2023 5:40 PM EDT
Scientists may have discovered mechanism behind cognitive decline in aging
University of Colorado Anschutz Medical Campus

Scientists at the University of Colorado Anschutz Medical Campus have discovered what they believe to be the central mechanism behind cognitive decline associated with normal aging.

Newswise: Belly Fat Hinders Digestive Disease Medications
Released: 25-Jul-2023 1:50 PM EDT
Belly Fat Hinders Digestive Disease Medications
Cedars-Sinai

The mass and composition of our bodies can significantly affect the way medications are metabolized and absorbed. Investigators at Cedars-Sinai found that inflammatory bowel disease (IBD) patients with higher levels of intra-abdominal visceral adipose tissue– a distinctive type of fat inside the abdomen −had lower rates of remission when treated with certain anti-inflammatory medications.

Released: 25-Jul-2023 12:55 PM EDT
Researchers use Argonne X-rays to find the best antibodies
Argonne National Laboratory

Antibody therapies are only effective if the antibodies do what we want them to do. This research can help scientists determine if an antibody is likely to stick to something other than the intended target, which should lessen the amount of time wasted with overly sticky antibodies.

19-Jul-2023 10:00 AM EDT
ADLM Announces 2023 Top Corporate Supporter Award Recipients and Thanks Them for Invaluable Support
Association for Diagnostic and Laboratory Medicine (ADLM (formerly AACC))

The Association for Diagnostics & Laboratory Medicine (ADLM) is pleased to announce the recipients of its 2023 Top Corporate Supporter Award.

Released: 25-Jul-2023 7:25 AM EDT
A Common Diabetes Drug Has a Surprising Side Gig: Muscle Protector
University of Utah Health

You might not think of diabetes when you think of muscle function. But a common diabetes drug that regulates blood sugar can also prevent muscle atrophy and muscular fibrosis—which can help the elderly bounce back faster from injury or illness.

Not for public release

This news release is embargoed until 24-Jul-2023 5:00 PM EDT Released to reporters: 18-Jul-2023 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 24-Jul-2023 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 24-Jul-2023 2:05 PM EDT
100-Year-Old Treatment Inhibits COVID-19 Infection
Rensselaer Polytechnic Institute (RPI)

A team of researchers led by Rensselaer Polytechnic Institute’s Jonathan S. Dordick, Ph.D., Institute Professor of Chemical and Biological Engineering, has illuminated a new possibility for the treatment and prevention of COVID-19 in research published in Communications Biology.

Released: 24-Jul-2023 12:05 PM EDT
Technology Developed at Rutgers Sublicensed to Global Biopharmaceutical Company
Rutgers University's Office for Research

Base editing technology invented at Rutgers, The State University of New Jersey, and exclusively licensed to Revvity, Inc. subsidiary Horizon Discovery, has been sub-licensed to biopharmaceutical company AstraZeneca to support its creation of cell therapies for the treatment of cancer and immune-mediated diseases.

19-Jul-2023 10:00 AM EDT
AACC Rebrands to the Association for Diagnostics & Laboratory Medicine
Association for Diagnostic and Laboratory Medicine (ADLM (formerly AACC))

AACC, a global scientific and medical professional organization dedicated to better health through laboratory medicine, is pleased to announce a name change to the Association for Diagnostics & Laboratory Medicine.

Released: 21-Jul-2023 2:10 PM EDT
Bodybuilding Supplement May Help Stave off Alzheimer’s
RUSH

The secret to protecting your memory may be a staple of a bodybuilder’s diet. RUSH researchers recently discovered that a muscle-building supplement called beta-hydroxy beta-methylbutyrate, also called HMB, may help protect memory, reduce plaques and ultimately help prevent the progression of Alzheimer’s disease.

Released: 21-Jul-2023 10:25 AM EDT
Medication for abortion or miscarriage management unavailable at most Hamilton, Ontario pharmacies survey finds
McMaster University

A medication commonly used for abortion or miscarriage management is only available at six per cent of Hamilton, Ont. pharmacies, according to a McMaster University-led survey.

Newswise: Powerhouse proteins protect heart cells from chemotherapy damage 
Released: 20-Jul-2023 2:05 PM EDT
Powerhouse proteins protect heart cells from chemotherapy damage 
University of Illinois Chicago

Researchers at the University of Illinois Chicago have identified a process by which enzymes can help prevent heart damage in chemotherapy patients

   
Released: 20-Jul-2023 12:30 PM EDT
Tell us how you really feel -- keep up with the latest research in Psychology and Psychiatry
Newswise

The latest research in psychology and psychiatry on Newswise.

       
Newswise: New Advancements in Assay Development Research
Released: 20-Jul-2023 11:00 AM EDT
New Advancements in Assay Development Research
SLAS

The July 2023 issue of SLAS Discovery, the open access journal focused on research progressing drug discovery, is now available.

   
Newswise: One pill doesn’t fit all: cholesterol study reveals effects on lung function and brain size
Released: 19-Jul-2023 10:40 PM EDT
One pill doesn’t fit all: cholesterol study reveals effects on lung function and brain size
University of South Australia

The first study in the world to compare cholesterol-lowering medications on a range of diseases has good and bad news for more than 200 million people.

Released: 19-Jul-2023 5:00 PM EDT
Heroes of Chemistry recognized for advancement in global health and environment
American Chemical Society (ACS)

The American Chemical Society will honor researchers and companies as Heroes of Chemistry for developing products that have led to significant advancements in improving health and the environment.

   
17-Jul-2023 2:30 PM EDT
Treatment at the First Signs of MS Could Mean Lower Risk of Disability Later
American Academy of Neurology (AAN)

People who start taking medication soon after the first signs of multiple sclerosis (MS) may have a lower risk of disability later, according to a study published in the July 19, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology.

Newswise: A new strategy for fentanyl overdoses
Released: 19-Jul-2023 2:35 PM EDT
A new strategy for fentanyl overdoses
Indiana University

Researchers at Indiana University have identified a new method of reversing the effects of fentanyl. Their study could lead to a new way to reverse overdoses either through a new product or working synchronously with naloxone.

Released: 19-Jul-2023 12:15 PM EDT
Towards new antibiotics with the first artificial synthesis of tanzawaic acid b
Tokyo University of Science

The discovery of antibiotics in 1928 was a major turning point in the history of medicine. For the first time since the dawn of human civilization, doctors had gained access to an extremely powerful and effective tool to fight against a wide variety of bacterial infections.

Newswise: Developing NMR method for drug structure elucidation
Released: 19-Jul-2023 12:00 AM EDT
Developing NMR method for drug structure elucidation
National Research Council of Science and Technology

Drs. Jinwook Cha and Jinsoo Park of the Natural Product Informatics Research Center at the Korea Advanced Institute of Science and Technology (KIST) announced that they have developed the first NMR method (Ultraselective Heteronuclear Polarization Transfer Method, or UHPT) that can selectively measure the information of carbon atom nuclei linked to specific hydrogen in a single measurement.

   
Newswise: VUMC receives $7 million award from PCORI to compare breathing tube sedation
Released: 18-Jul-2023 2:25 PM EDT
VUMC receives $7 million award from PCORI to compare breathing tube sedation
Vanderbilt University Medical Center

  Vanderbilt University Medical Center has received a $7 million, five-year funding award from PCORI (Patient-Centered Outcomes Research Institute) to compare two sedatives used to place breathing tubes in the emergency department (ED) or intensive care unit (ICU). To provide support with a breathing machine, doctors must place a breathing tube into a patient’s mouth and throat, and they are given a medication to make them sleep during this procedure.

Released: 18-Jul-2023 1:45 PM EDT
Halo Labs Unveils Aura+ Subscription Program for Convenient and Affordable Particle Analysis
Halo Labs

Halo Labs, a pioneer in life science instrumentation, announced the launch of its new Aura®+ Subscription Program.

Released: 17-Jul-2023 5:00 PM EDT
AANA Appoints Ladan Eshkevari as New Editor-In-Chief of The AANA Journal
American Association of Nurse Anesthesiology

The American Association of Nurse Anesthesiology (AANA) has named Ladan Eshkevari, PhD, CRNA, L.Ac.,FAAN to serve as AANA’s Editor-in-Chief of The AANA Journal.

Newswise: World-first clinical trial to help millions with penicillin allergies
Released: 17-Jul-2023 11:55 AM EDT
World-first clinical trial to help millions with penicillin allergies
Vanderbilt University Medical Center

Penicillin allergy affects more than 25 million people in the United States (up to 1 in 10 Americans) and has been shown to lead to particularly poor health outcomes in pregnant women and surgical patients. It is also a public health threat, leading to antibiotic resistance and infections in hospitalized patients that can be life threatening.

Newswise: Breaking Barriers in Drug Delivery with Better Lipid Nanoparticles
Released: 17-Jul-2023 10:40 AM EDT
Breaking Barriers in Drug Delivery with Better Lipid Nanoparticles
Lawrence Berkeley National Laboratory

Berkeley Lab and Genentech are collaborating to make the next generation of lipid nanoparticles (LNPs) for drug delivery. Combining structural biology with cutting edge pharmaceutical science, the team is designing LNPs that can precisely deliver vaccines and therapeutics to target tissues while improving the product’s shelf life and duration of action.

Released: 14-Jul-2023 4:45 PM EDT
Ketamine effective for treatment-resistant depression: clinical trial
University of New South Wales

A low-cost version of ketamine to treat severe depression has performed strongly in a double-blind trial that compared it with placebo.

Released: 14-Jul-2023 1:55 PM EDT
AI brings hope for patients with lyosomal storage disease
University of Zurich

Artificial intelligence is becoming increasingly important in drug discovery.

Newswise: Tau-based biomarker tracks Alzheimer’s progression
12-Jul-2023 5:05 PM EDT
Tau-based biomarker tracks Alzheimer’s progression
Washington University in St. Louis

Researchers at Washington University School of Medicine in St. Louis and Lund University in Sweden have discovered an Alzheimer's biomarker in the cerebrospinal fluid known as MTBR-tau243 can be used to track the progression of disease and could speed drug development.



close
2.44749